Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134300 · ClinicalTrials.gov registry record · NA
Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03134300 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 15 participants.
The verdict
NCT03134300, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The investigators wish to study the role of persistent markers of inflammation in executive function in young children during critical periods of synaptogenesis (ages 2-3). While the role of markers of inflammation have been validated in the pathogenesis in multiple disorders in the adult population, their study in pediatrics is limited. The investigators therefore propose that demonstration of persistent cytokine inflammatory markers in this preliminary study will allow larger studies to proceed.
Interventions
- DIAGNOSTIC_TEST Cytokine from blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03134300
The ClinicalTrials.gov registry entry for NCT03134300 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cytokine from blood is the first listed.
NCT03134300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03134300 about?
NCT03134300 is a clinical study titled "Cytokine Persistence as a Marker of Inflammation in the at Risk, Low Socioeconomic Status Pediatric Population". The investigators wish to study the role of persistent markers of inflammation in executive function in young children during critical periods of synaptogenesis (ages 2-3). While the role of markers of inflammation have been validated in the pathogenesis in multiple disorders in the adult population...
What is the current status of trial NCT03134300?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-01-29. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03134300?
The interventions under investigation include: Cytokine from blood (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03134300?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.